Evidence-Based Guide

Epinephrine Auto-Injector (EpiPen) Prescription & Usage Guide

Anaphylaxis recognition, device selection, injection technique, dosing, and when to seek emergency care — from a board-certified physician.

Key Takeaways

  • Epinephrine is the only first-line treatment for anaphylaxis. Antihistamines are not a substitute — they do not stop a systemic allergic reaction.
  • The standard adult dose is 0.3 mg; the pediatric dose for children 15–30 kg is 0.15 mg. Always carry two devices.
  • Inject into the outer mid-thigh, through clothing if necessary. Speed matters more than skin preparation.
  • If symptoms do not improve within 5–15 minutes, use the second device and call 911.
  • Always go to the emergency room after using epinephrine — biphasic reactions can occur up to 72 hours later.
  • Telehealth visits are a valid and convenient pathway to obtain or renew an epinephrine auto-injector prescription.

Anaphylaxis kills. Not because treatments do not exist — they do — but because too many people hesitate, reach for an antihistamine instead of epinephrine, or wait to see if symptoms will pass on their own. Every year, approximately 225 people in the United States die from anaphylaxis.[3] The majority of those deaths involve a delay in epinephrine administration.

What I tell every patient who carries an epinephrine auto-injector: the device only works if you use it — and use it early. Studies show that only 11% of people self-administer epinephrine when they experience a reaction.[3] The 27% who reach for antihistamines instead are taking a risk that is not supported by any clinical evidence.

This guide covers everything you need to know about epinephrine auto-injectors: which device to use, how to use it correctly, how to recognize anaphylaxis before it progresses, and when a telehealth visit is appropriate for getting or renewing your prescription.

Recognizing Anaphylaxis: What Happens and How Fast

Anaphylaxis is a severe, systemic allergic reaction that involves two or more organ systems and can become life-threatening within minutes of allergen exposure. Onset is typically rapid — symptoms can begin within seconds to a few minutes of contact with a trigger, though reactions to food allergens sometimes take 20–30 minutes to build.

The 2023 Joint Task Force Practice Parameter, developed collaboratively by the American Academy of Allergy, Asthma & Immunology (AAAAI) and the American College of Allergy, Asthma & Immunology (ACAAI), defines anaphylaxis as highly likely when any of three clinical scenarios is met.[1]

Clinical Criteria for Anaphylaxis (AAAAI/ACAAI 2023)

Scenario 1: Acute skin or mucous membrane symptoms (hives, flushing, swelling) plus respiratory compromise OR low blood pressure — occurring rapidly after allergen exposure.

Scenario 2: Rapid involvement of two or more organ systems after exposure to a likely allergen — any combination of skin symptoms, respiratory symptoms, low blood pressure, or sudden gastrointestinal symptoms.

Scenario 3: Sudden drop in blood pressure after exposure to a known allergen for that patient.

Symptoms by Organ System

Recognizing anaphylaxis means knowing what it looks like across the body simultaneously. The skin is involved in 73–98% of reactions — hives, flushing, and swelling are usually the first signs you will see.[3] But skin symptoms alone do not define anaphylaxis; the danger lies in what happens to the airway and cardiovascular system at the same time.

Organ System Common Symptoms Frequency
Skin & Mucous Membranes Hives, itching, flushing, swelling (lips, tongue, face) 73–98%[3]
Respiratory Throat tightening, hoarseness, stridor, wheezing, difficulty breathing 74–81%[3]
Cardiovascular Rapid heart rate, low blood pressure, dizziness, chest pain, collapse 31–39%[3]
Gastrointestinal Cramping, nausea, vomiting, diarrhea 17–33%[3]
Neurological Anxiety, confusion, sense of impending doom Variable
Antihistamines Will Not Stop Anaphylaxis

This is one of the most dangerous misconceptions I encounter. Antihistamines block histamine receptors — they relieve itching and hives. They do not reverse bronchospasm, restore blood pressure, or stop airway swelling. If you take Benadryl during anaphylaxis, you may temporarily mask skin symptoms while the systemic reaction continues unchecked. Epinephrine is the only medication that addresses the life-threatening components of an anaphylactic reaction.

Biphasic Anaphylaxis: Why You Must Go to the ER

Biphasic anaphylaxis is the return of anaphylaxis symptoms after complete resolution of the initial reaction — without any additional allergen exposure. Research from the European Anaphylaxis Registry found that approximately 4.7% of anaphylaxis cases follow a biphasic course, with the second phase occurring anywhere from 1 to 72 hours after initial symptom resolution.[5]

Risk factors for biphasic reactions include a severe initial reaction, multiorgan involvement, reactions triggered by peanuts or tree nuts, exercise as a cofactor, delayed epinephrine administration, and a history of chronic urticaria.[5] There is currently no reliable way to predict who will have a biphasic reaction. That is why the standard of care is hospital observation after every episode requiring epinephrine.

Common Triggers for Anaphylaxis

Knowing your triggers is the first line of defense. Anaphylaxis affects an estimated 1 in 20 Americans at some point in their lives.[6] The three main categories — foods, medications, and insect stings — account for the vast majority of cases.

Food Triggers

Food is the most common cause overall, responsible for 32–37% of anaphylaxis cases.[3] In children, food allergy is by far the leading trigger. The "Big Nine" allergens — peanuts, tree nuts, shellfish, fish, milk, eggs, wheat, soy, and sesame — collectively account for most food-induced anaphylaxis. Peanuts carry particular risk: reactions to peanut are more likely to be biphasic than reactions to other foods, with a biphasic rate of 9.6% compared to the 4.7% overall average.[5]

Insect Stings

Hymenoptera stings — from bees, wasps, hornets, yellow jackets, and fire ants — cause 15–25% of anaphylaxis cases and account for approximately 72 deaths per year in the United States.[3] Venom allergy is a particularly important diagnosis to establish formally, because venom immunotherapy (allergy shots) can reduce the risk of future anaphylaxis from sting reactions by 80–95%.

Medications

Medications are responsible for 21–59% of anaphylaxis cases and are the top cause in adults.[3] Non-steroidal anti-inflammatory drugs (NSAIDs) alone account for 48.7–58.8% of medication-related cases. Antibiotics — particularly penicillin and amoxicillin — are another frequent culprit. If you have had an anaphylactic reaction to a medication, carrying an epinephrine auto-injector is appropriate given the risk of accidental re-exposure.

Exercise-Induced and Idiopathic Anaphylaxis

Exercise-induced anaphylaxis is a distinct condition in which physical exertion triggers a systemic reaction. Some patients have food-dependent exercise-induced anaphylaxis, where eating a specific food within a few hours before exercise is required to provoke a reaction — the food alone and the exercise alone are both tolerated, but the combination is not. This diagnosis is easy to miss if the pattern is not recognized.

Idiopathic anaphylaxis — where no trigger can be identified after thorough evaluation — accounts for 11–19.5% of cases.[3] Patients with idiopathic anaphylaxis often have more frequent reactions and require long-term epinephrine auto-injector prescriptions and close follow-up with an allergist.

Epinephrine Auto-Injector Devices: EpiPen, Auvi-Q, and Generics

The FDA has approved several epinephrine auto-injector (EAI) devices. All deliver intramuscular epinephrine into the outer thigh. The differences come down to form factor, features, and cost — not clinical effectiveness. What matters most is which device you can use correctly and consistently under stress.

Device Doses Available Notable Features
EpiPen / EpiPen Jr 0.3 mg (adult), 0.15 mg (pediatric) Traditional pen-shaped device. Most widely recognized. Orange tip is the needle end; blue safety cap on top. Widely available at most pharmacies.
Auvi-Q 0.1 mg (infants 7.5–15 kg), 0.15 mg (pediatric 15–30 kg), 0.3 mg (adults ≥30 kg) Compact, credit card–shaped device. Provides step-by-step audio and visual instructions during use — a real advantage in a high-stress emergency. Retractable needle. Includes needle-cover retraction to confirm injection.[7]
Generic epinephrine auto-injectors 0.3 mg, 0.15 mg Bioequivalent to brand-name devices. Often lower cost. Technique may vary slightly between manufacturers — confirm proper use with your pharmacist when switching.

The 2023 AAAAI/ACAAI practice parameter recommends prescribing EAIs routinely to patients at higher risk of anaphylaxis, and using shared decision-making for lower-risk patients.[1] Shared decision-making means your physician will weigh your personal trigger history, reaction severity, access to emergency services, and lifestyle factors in deciding whether one or two devices is appropriate. In my practice, I routinely prescribe two auto-injectors — the reasoning is straightforward: you may need a second dose, and having only one when it is most needed is not a risk worth taking.

Dosing: Getting the Right Strength for Your Weight

Epinephrine dosing for anaphylaxis is weight-based. The recommended dose is 0.01 mg/kg, up to a maximum of 0.3 mg for children and teenagers and 0.5 mg for adults per the 2023 AAAAI/ACAAI guidelines.[1] In practice, auto-injectors come in fixed doses, so the weight thresholds below guide which device to prescribe.

Patient Weight Recommended Dose Device Options
7.5–15 kg (approx. 16.5–33 lbs) 0.1 mg Auvi-Q 0.1 mg
15–30 kg (approx. 33–66 lbs) 0.15 mg EpiPen Jr, Auvi-Q 0.15 mg, generic 0.15 mg
≥30 kg (approx. 66 lbs and above) 0.3 mg EpiPen, Auvi-Q 0.3 mg, generic 0.3 mg

Some expert consensus supports transitioning children from the 0.15 mg to the 0.3 mg dose once they reach 25 kg, rather than waiting for 30 kg.[2] Discuss this with your child's physician at each annual review — dose reassessment should accompany every weight check.

For infants under 7.5 kg, no commercial auto-injector is currently sized appropriately. These cases require individualized guidance from a specialist. If your infant is at risk of anaphylaxis and weighs less than 7.5 kg, speak directly with a pediatric allergist about your options.

How to Use an Epinephrine Auto-Injector: Step-by-Step

Proper technique is non-critical to the success of the injection — intramuscular epinephrine into the thigh achieves faster and higher peak plasma concentrations than subcutaneous injection.[2] The outer mid-thigh is the only recommended injection site. Here is the general technique applicable to EpiPen and most auto-injectors:

  1. Call 911 first (or have someone else call while you prepare the device).
  2. Remove the device from its carrying case. Do not remove the safety cap until you are ready to inject.
  3. Remove the safety cap (blue cap on EpiPen; pull tab on Auvi-Q). Do not put your thumb, finger, or hand over the tip.
  4. Place the tip against the outer mid-thigh — through clothing is acceptable. Do not inject into the buttocks, hands, feet, or intravenously.
  5. Press firmly until you hear and feel a click. The needle deploys automatically.
  6. Hold in place for 3 seconds (EpiPen/generic) or until the orange needle guard extends (Auvi-Q provides audio confirmation). Older guidance recommended 10 seconds, but current evidence supports 3 seconds as sufficient.
  7. Remove the device and massage the injection site for 10 seconds to aid absorption.
  8. Note the time of injection. If no improvement in 5–15 minutes, use the second auto-injector in the opposite thigh.
  9. Go to the emergency room — even if symptoms have fully resolved.
Injecting Through Clothing Is Acceptable

You do not need to remove clothing or prepare the skin before injecting. In an emergency, removing a layer of clothing wastes time that matters. The needle on all commercial auto-injectors is long enough to reach the muscle through a standard layer of fabric. Jeans, athletic pants, and similar clothing are all acceptable.

When to Use a Second Dose

Both EpiPen and Auvi-Q are dispensed in packs of two auto-injectors — that is not accidental. Use the second device if your symptoms are not improving or are getting worse 5–15 minutes after the first injection.[7]

The 2023 guidelines specify that patients who have previously required multiple doses of epinephrine or who have a history of biphasic reactions may be candidates for carrying more than two devices.[1] If that describes your history, ask your physician about prescribing three or four devices and whether your action plan should be updated accordingly.

If you have used two doses and you are still symptomatic — or if symptoms return — call 911 immediately. You will need IV epinephrine that only paramedics and emergency physicians can administer. Do not delay calling because you are waiting to see whether the second dose "kicks in."

Carrying Two Devices, Managing Expiration, and Cost

Always Carry Two

The 2023 AAAAI/ACAAI guidelines and the Auvi-Q prescribing information both state clearly: carry two devices at all times.[1][7] Anaphylaxis does not announce itself conveniently — reactions happen at school, at work, at restaurants, on planes, and during exercise. Having a single device that gets accidentally left at home, left in a hot car, or is expired when you reach for it represents a real and preventable risk.

Practical carrying strategies include: a dedicated insulated auto-injector case worn on the body, a second set kept at school or the workplace, and a device in every bag you regularly carry. Make it a habit — like a phone or wallet, it leaves with you every time.

Expiration and Inspection

Check the expiration date on your devices monthly. Set a calendar reminder 30–60 days before expiration so you have adequate time to obtain a refill. Between checks, inspect the viewing window: the solution should be clear and colorless. Discolored, cloudy, or particulate-containing solution should not be used even if the device is technically unexpired.

Do not store auto-injectors in extreme heat or cold. The recommended storage temperature is room temperature — 59°F to 86°F (15°C to 30°C). A hot car dashboard in summer can exceed 150°F and degrade the medication. An insulated carrying case is worth the investment.

Cost and Access

The direct costs associated with anaphylaxis in the United States exceed $1.2 billion annually, with approximately $294 million spent on epinephrine alone.[3] Brand-name EpiPens can be expensive without adequate insurance coverage. Generic epinephrine auto-injectors are bioequivalent and substantially less costly. Auvi-Q offers a patient assistance program that allows eligible patients to obtain the device at reduced or no cost. Ask your physician or pharmacist about generic options, manufacturer coupons, and assistance programs before paying out-of-pocket for brand-name devices.

Your Anaphylaxis Action Plan

Every patient prescribed an epinephrine auto-injector should have a written anaphylaxis action plan — a single-page document that outlines their known triggers, symptom recognition criteria, when to use epinephrine, and what to do after injection. These are available from FARE (Food Allergy Research & Education) and AAFA (Asthma and Allergy Foundation of America) and should be customized by your physician to reflect your specific history.

School and Workplace Policies

All 50 U.S. states permit students to carry and self-administer epinephrine at school.[3] A 2016 survey found that 31.8% of school nurses reported at least one anaphylaxis episode at their school in the prior year, and 25% of students who experienced a severe reaction at school had no previously diagnosed severe allergy — meaning the reaction was entirely unexpected.[3] Having a written action plan on file with your child's school nurse is not optional; it is standard of care.

For adults, register your condition with your employer's occupational health or HR department so a colleague can assist if needed. Many workplaces are now required or encouraged to stock undesignated epinephrine auto-injectors for community use under state laws — check the requirements in your state.

Exercise-Induced Anaphylaxis: Special Considerations

If you have exercise-induced anaphylaxis or food-dependent exercise-induced anaphylaxis, your action plan needs to account for workout settings. Always exercise with a partner who knows your condition and knows where your auto-injectors are. Do not exercise alone in isolated areas. Your action plan should specify the foods to avoid before exercise and the minimum interval between eating and physical activity that your allergist recommends.

Telehealth's Role in Prescribing and Refilling Epinephrine Auto-Injectors

A telehealth visit is an appropriate and efficient pathway to obtain or renew an epinephrine auto-injector prescription. Most auto-injector prescriptions are renewals — patients with established food allergy, venom allergy, or prior anaphylaxis who need a new prescription before their current devices expire. A secure video visit allows a physician to review your allergy history, confirm that your current diagnosis and risk level still warrant an EAI, assess whether your prescribed dose remains appropriate (particularly in growing children), and send the prescription directly to your preferred pharmacy.

Telehealth is also valuable for the initial assessment of patients who suspect they have had an anaphylaxis-level reaction and want guidance on whether an EAI is appropriate for them. While a formal allergy evaluation — with skin prick testing and specific IgE measurement — is typically performed by an in-person allergist, the preliminary history and prescription can often be addressed in a telehealth setting while that referral is being arranged.

When should you see an allergist in person rather than managing this via telehealth alone? If you have never had a formal allergy evaluation, if your trigger is unknown (idiopathic anaphylaxis), if you have had multiple reactions despite carrying epinephrine, or if you are a candidate for venom immunotherapy, an in-person allergist visit is warranted. Telehealth and in-person allergy care work best as complements, not substitutes.

When to Contact TeleDirectMD

Call 678-956-1855 or email contact@teledirectmd.com to schedule a telehealth visit for epinephrine auto-injector prescription, renewal, or dose reassessment. Available across 35+ licensed U.S. states. No insurance required.

Why You Must Go to the ER After Using Epinephrine — Every Time

I hear patients say: "But I feel completely fine now. Do I really have to go?" Yes. Every time.

Epinephrine has a short half-life — the medication wears off within 15–20 minutes. The anaphylactic process it suppressed is still occurring at the cellular level. Biphasic reactions — the return of anaphylaxis after apparent recovery — occur in approximately 4.7% of cases and can develop up to 72 hours after the initial reaction.[5] You cannot predict whether you will be in that 4.7%.

Emergency observation allows medical staff to monitor your vital signs, administer a second dose of epinephrine or IV epinephrine if needed, give adjunctive medications (corticosteroids, antihistamines, bronchodilators), and discharge you with a full action plan. The guidelines from AAAAI/ACAAI specify that for patients at higher risk for biphasic reactions — those with severe initial reactions or multiorgan involvement — an observation period of 6 hours or longer should be strongly considered.[4]

The one scenario where immediate EMS activation may not be strictly required: if your reaction was mild, resolved promptly and completely after a single dose of epinephrine, and you have access to additional devices and someone who can assist you if symptoms return. Even then, I advise my patients to get evaluated. The cost of a precautionary ER visit is always lower than the cost of an untreated biphasic reaction at home.

Frequently Asked Questions

Yes. In the United States, epinephrine auto-injectors — including EpiPen, Auvi-Q, and generic versions — require a prescription. A physician must evaluate your history of allergic reactions and determine that you meet criteria for carrying one. Telehealth visits are a convenient way to obtain or renew this prescription without visiting an in-person clinic.

Both deliver intramuscular epinephrine and are FDA-approved for anaphylaxis. EpiPen is the traditional pen-shaped device available in 0.15 mg (Jr) and 0.3 mg doses. Auvi-Q is a smaller, rectangular device that provides audio and visual instructions step-by-step, which can be helpful in a high-stress emergency. Both come in packs of two devices. The choice comes down to personal preference, insurance coverage, and which device you can use most reliably under pressure.

Use a second auto-injector 5 to 15 minutes after the first if your symptoms are not improving or are worsening. Both EpiPen and Auvi-Q are dispensed in packs of two for this reason. If you have used two doses and symptoms persist, call 911 — you need IV epinephrine from emergency medical services. Do not delay calling 911 while waiting to see if the second dose works.

Biphasic anaphylaxis is a real risk. This is when symptoms resolve after epinephrine but then return hours later — sometimes up to 72 hours — without any additional allergen exposure. The rate of biphasic reactions is approximately 4.7% of all anaphylaxis cases, and it can occur even after a reaction that seemed mild initially. Emergency observation allows medical staff to monitor you and administer additional treatment if needed.

No. Antihistamines are not a treatment for anaphylaxis. They address itching and hives — surface-level symptoms — but do not stop the systemic reaction affecting your airway, blood pressure, and cardiovascular system. Reaching for Benadryl during anaphylaxis delays epinephrine and increases the risk of a fatal outcome. Epinephrine is the only first-line treatment. Antihistamines may be given after epinephrine as a secondary measure for symptom comfort, but they do not replace it.

Check the expiration date printed on the device label and outer packaging. Also inspect the viewing window — the solution should be clear and colorless. If it appears discolored, cloudy, or has visible particles, do not use it even if not yet expired. Set a calendar reminder 30 days before expiration so you have time to request a refill. An expired auto-injector may still deliver some epinephrine in a true emergency — use it if it is all you have and call 911 immediately — but do not routinely carry expired devices.

Dosing is weight-based. Children weighing 15 to 30 kg (approximately 33 to 66 lbs) typically receive the 0.15 mg auto-injector (EpiPen Jr or Auvi-Q 0.15 mg). Children weighing 30 kg or more receive the standard 0.3 mg adult dose. For very young children between 7.5 and 15 kg, Auvi-Q offers a 0.1 mg device. Your child's physician should reassess the prescribed dose at every annual visit — children grow, and the appropriate dose changes with weight.

Yes. In most U.S. states, a telehealth physician can evaluate your allergy history and prescribe or renew an epinephrine auto-injector prescription during a secure video visit. This is especially valuable for patients managing known food allergies, insect sting allergy, or idiopathic anaphylaxis who need prescription refills between in-person allergist appointments. TeleDirectMD is available for these visits across 35+ licensed U.S. states.

The most common triggers are foods (32–37% of cases), medications (21–59%), and insect stings (15–25%). The leading food triggers are peanuts, tree nuts, shellfish, milk, and eggs. Among medications, NSAIDs and antibiotics (particularly penicillins) are the most frequent culprits. In adults, medications and insect stings are the top causes; in children, food allergy dominates. About 11–19% of cases are idiopathic, meaning no trigger is identified despite thorough evaluation.

Store your auto-injector at room temperature — between 59°F and 86°F (15°C to 30°C). Keep it away from direct light and heat. Do not refrigerate or freeze it; extreme cold can affect the device mechanism. Never leave it in a hot car. Carry it in an insulated case if you live in a hot climate or are traveling. Inspect the solution through the viewing window regularly — it should remain clear and colorless.

References

  1. Golden DBK, Wang J, Waserman S, et al. Anaphylaxis: A 2023 Practice Parameter Update. Ann Allergy Asthma Immunol. 2024;132(2):124–176. https://pubmed.ncbi.nlm.nih.gov/38108678/
  2. Prince BT, Mikhail I, Stukus DR. Underuse of Epinephrine for the Treatment of Anaphylaxis. Journal of Asthma and Allergy. 2018;11:143–151. https://pmc.ncbi.nlm.nih.gov/articles/PMC6016581/
  3. Allergy & Asthma Network. Anaphylaxis Statistics. https://allergyasthmanetwork.org/anaphylaxis/anaphylaxis-statistics/
  4. Patel N, Sanjiv S, et al. Anaphylaxis: Highlights from the Practice Parameter Update. Cleveland Clinic Journal of Medicine. 2022;89(2):106–112. https://www.ccjm.org/content/89/2/106
  5. Kraft M, Schaper A, Rueff F, et al. Risk Factors and Characteristics of Biphasic Anaphylaxis. Journal of Allergy and Clinical Immunology: In Practice. 2020;8(9):3143–3151. https://pubmed.ncbi.nlm.nih.gov/32763470/
  6. Asthma and Allergy Foundation of America (AAFA). Anaphylaxis in America. https://aafa.org/asthma-allergy-research/our-research/anaphylaxis-in-america/
  7. Kaleo Therapeutics. How to Use AUVI-Q® (epinephrine injection, USP). https://www.auvi-q.com/about-auvi-q
  8. American College of Allergy, Asthma & Immunology (ACAAI). New Guidelines Released for Practitioners Treating Anaphylaxis. December 19, 2023. https://acaai.org/news/new-guidelines-released-for-practitioners-treating-anaphylaxis-and-atopic-dermatitis/

About the Author

TeleDirectMD Medical Team

The TeleDirectMD Medical Team includes board-certified physicians specializing in allergy, immunology, and primary care. Our clinicians evaluate and manage anaphylaxis risk, prescribe epinephrine auto-injectors, and provide anaphylaxis action plan counseling via secure telehealth visits across 35+ licensed U.S. states.

Medically reviewed by TeleDirectMD Medical Team — Last reviewed March 2026